No Data
No Data
Nyrada Says First Cohort Data of Phase One Clinical Trial Reviewed by Safety Review Committee, Shares Rise 5%
Study Finds Nyrada's Lead Drug Can Prevent Secondary Brain Injury
Nyrada Doses First Cohort in NYR-BI03's Phase I Human Clinical Trial
ASX Midday Sector Update: Materials Stocks Soar, Healthcare Stocks Fall
Nyrada Begins Patient Recruitment for NYR-BI03 Phase Ia Clinical Trial
Nyrada Inc: Nyrada Half Year Results FY2025
151479178 : What are you talking about
hopeful Andy : what have you invested in. now